Recruiting studies: Generalized Seizure

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study to Evaluate the Safety and Pharmacokinetics of RC001 in Children With Dravet Syndrome
EARLY_Phase 1 · 1 location(s) · Second Affiliated Hospital of Guangzhou Medical University · NCT07675746 Etiology and Treatment of Neonatal Seizure
Phase N/A · 1 location(s) · Children's Hospital of Fudan University · NCT03822741 An Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal Onset or Tonic-Clonic Seizures
Phase 2 · 11 location(s) · Praxis Precision Medicines · NCT06908356 Optimizing Therapy in Epilepsy Using Seizure Forecasts Via EEG and Wearables
NA · 1 location(s) · Mayo Clinic · NCT07012148 LEvetiracetam to Prevent Seizures in Symptomatic Alzheimer's Disease in Adults With Down Syndrome
Phase 3 · 5 location(s) · Fundació Institut de Recerca de l'Hospital de la Santa Creu · NCT07234695 Ketamine and Levetiracetam as Second-line Antiseizure Medication for Status Epilepticus in Children
Phase 2/Phase 3 · 1 location(s) · Sohag University · NCT07046611 A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
Phase 3 · 138 location(s) · Xenon Pharmaceuticals Inc. · NCT05667142 ONO-2017 Study Japanese Patients With Primary Generalized Tonic Clonic Seizures.
Phase 3 · 25 location(s) · Ono Pharmaceutical Co., Ltd. · NCT06579573 A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndro
Phase 1/Phase 2 · 14 location(s) · Encoded Therapeutics · NCT05419492 A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS)
Phase 3 · 102 location(s) · Longboard Pharmaceuticals · NCT06660394 Epilepsy Learning Healthcare System (ELHS)
Phase N/A · 13 location(s) · Epilepsy Foundation of America · NCT06265103 A Study to Evaluate the Safety of Fycompa Injection in Participants With Partial-Onset Seizures or Primary Generalized T
Phase N/A · 1 location(s) · Eisai Co., Ltd. · NCT06657378 Prophylactic Anti-Seizure Medication vs No Anti-Seizure Medication for Patients With Primary Motor Cortex Brain Metastas
Phase 2 · 1 location(s) · Ayal A. Aizer, MD · NCT07130786 A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome
Phase 3 · 60 location(s) · Epygenix · NCT04462770 A Clinical Study on the Efficacy and Safety of Zonisamide as a First Add-On Treatment in Epileptic Seizures
Phase 4 · 1 location(s) · Affiliated Hospital of Nantong University · NCT06967012 Exogenous Ketone Esters for Refractory Status Epileptics
Phase 2/Phase 3 · 1 location(s) · Sohag University · NCT05674552 Non-Invasive Low Intensity Focused Ultrasound Stimulation for Drug-Resistant Epilepsy
NA · 1 location(s) · University of California, San Francisco · NCT07680842 Ketogenic Diet for Prevention of Epileptic Spasms in Infantile Onset Genetic Epilepsies
Phase 1 · 1 location(s) · Heather Olson · NCT06700811 A Study Evaluating NPT 2042 Versus Placebo in Subjects Aged 16-75 Years With Genetic Generalized Epilepsy (GGE) and Abse
Phase 2 · 1 location(s) · NeuroPro Therapeutics, Inc. · NCT06769659 Register for Patients With Thyroid Hormone Resistance.
Phase N/A · 1 location(s) · Charite University, Berlin, Germany · NCT06566066

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.